Abbott Laboratories (ABT) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $111.27 +0.32%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
OFLX, AFIB, NMRD, More
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
OFLX, AFIB, NMRD, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.51, $0.01 better than the analyst estimate of $1.50. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.58 billion.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- KULR Technology Group (KULR) Misses Q2 EPS by 39c
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
